| 2024 |
Protocol for generation and engineering of thyroid cell lineages using CRISPR-Cas9 editing to recapitulate thyroid cancer histotype progression |
Articolo in rivista |
Go to |
| 2023 |
EBF1, MYO6 and CALR expression levels predict therapeutic response in diffuse large B-cell lymphomas |
Articolo in rivista |
Go to |
| 2023 |
Recapitulating thyroid cancer histotypes through engineering embryonic stem cells |
Articolo in rivista |
Go to |
| 2022 |
Effective targeting of breast cancer stem cells by combined inhibition of Sam68 and Rad51 |
Articolo in rivista |
Go to |
| 2022 |
Dual Inhibition of Myc Transcription and PI3K Activity Effectively Targets Colorectal Cancer Stem Cells |
Articolo in rivista |
Go to |
| 2022 |
Targeting epigenetic alterations in cancer stem cells |
Review essay (rassegna critica) |
Go to |
| 2021 |
Messing Up the Cancer Stem Cell Chemoresistance Mechanisms Supported by Tumor Microenvironment |
Review essay (rassegna critica) |
Go to |
| 2020 |
Cancer Stem Cells in Thyroid Tumors: From the Origin to Metastasis |
Articolo in rivista |
Go to |
| 2020 |
Metabolic Escape Routes of Cancer Stem Cells and Therapeutic Opportunities |
Review essay (rassegna critica) |
Go to |
| 2019 |
Cancer Stem Cells and Neuroblastoma: Characteristics and Therapeutic Targeting Options |
Articolo in rivista |
Go to |
